Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AnaptysBio, Inc. - Common Stock (NQ: ANAB )

13.89 -0.08 (-0.57%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 238,479
Open 13.91
Bid (Size) 12.50 (1)
Ask (Size) 14.35 (2)
Prev. Close 13.97
Today's Range 13.82 - 14.59
52wk Range 13.82 - 41.31
Shares Outstanding 27,433,359
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into AnaptysBio Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga

Performance

YTD
-35.99%
-35.99%
1 Month
-42.37%
-42.37%
3 Month
-57.05%
-57.05%
6 Month
-42.65%
-42.65%
1 Year
-35.34%
-35.34%

More News

Read More
AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data
Via Benzinga
Anaptys Announces Phase 2b Trial of ANB032, a BTLA Agonist, Did Not Meet Primary or Secondary Endpoints in Atopic Dermatitis
From AnaptysBio, Inc.
Via GlobeNewswire
Key Takeaways From AnaptysBio Analyst Ratings
Via Benzinga
A Glimpse Into The Expert Outlook On AnaptysBio Through 6 Analysts
Via Benzinga
What Analysts Are Saying About AnaptysBio Stock
Via Benzinga
Insiders Buying Yum China And 2 Other Stocks
Via Benzinga
Anaptys Announces Participation in November and December Investor Conferences
From AnaptysBio, Inc.
Via GlobeNewswire
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
From AnaptysBio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
O-I Glass Posts Downbeat Results, Joins AMD, Qorvo And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
4 Analysts Assess AnaptysBio: What You Need To Know
Via Benzinga
The Analyst Landscape: 7 Takes On AnaptysBio
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Anaptys Announces Participation in September Investor Conferences
From AnaptysBio, Inc.
Via GlobeNewswire
Why AnaptysBio Was Such a Healthy Stock This Week
Via The Motley Fool
UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
AnaptysBio Hits Five-Year High After Sanofi Takes A Stake In $100 Million Offering
Via Investor's Business Daily
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
Via Benzinga
Topics ETFs Economy Stocks
Exposures Interest Rates US Equities
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
From AnaptysBio, Inc.
Via GlobeNewswire
ANAB Stock Earnings: AnaptysBio Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
From AnaptysBio, Inc.
Via GlobeNewswire
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.